Skip to main content

December 2019

 

Clinical courses

Job for Pharmacists (07 posts) in Steel Authority of India Limited

Steel Authority of India Limited (SAIL) is the largest steel-making company in India and one of the seven Maharatna’s of the country’s Central Public Sector Enterprises. SAIL produces iron and steel at five integrated plants and three special steel plants, located principally in the eastern and central regions of India and situated close to domestic sources of raw materials. SAIL manufactures and sells a broad range of steel products.

Post : Pharmacist Intern

Vacancy for Junior Research Fellow, Project Assistant at National Dairy Research Institute

The National Dairy Research Institute as country's premier Dairy Research institution has developed considerable expertise over the last five decades in different areas of Dairy Production, Processing, Management and Human Resource Development. Information generated at the Institute and the services offered have contributed to the growth of Dairy Industry as a whole and well-being of millions of milk producers and consumers of milk and milk products. Realizing the challenging need of global Dairy Trade, the Institute is continuously working to develop its R&D and HRD programmes to better serve the nation in terms of food security, employment generation, poverty alleviation and economic prosperity.

Post : Junior Research Fellow and Project Assistant

Job for Junior Research Fellow, Research Associate at CIAB - Govt. of India

Center of Innovative and Applied Bioprocessing (CIAB) is an autonomous national institute under Department of Biotechnology (Govt. of India). This futuristic innovation institute of its own kind in the country has a mission of advancing knowledge, leads and emerging technologies/processes relevant to agri-food sector towards applications and products. It aims to link them with societal benefits through catalysing/promoting entrepreneurial action around bioprocesses, bio-products, value-addition to bioproducts etc. with special reference to the agri-food sector. Currently, the four major mandated R&D areas in hand at the institute are (A) Value Addition to Primary Processing Residues/ Wastes for Edible Products; (B) Valorisation of Crop Waste for Speciality Products and Chemicals; (C) Nutritionals, nutraceuticals and upgradation of value or use of bio-products, (D) Biosynthetic technology/synthetic biology for low volume-high value products and industrial enzymes.

Walk in interview for Junior Research Fellow at Presidency University

Presidency University has a unique place in history. It was one of the first institutes of Western-type higher education in Asia. In 1817, a group of enlightened Indians and Englishmen set up the Hindoo College.This was taken over the British Government in 1855 as the College of the Bengal Presidency, and placed in 1857 under the newly founded Calcutta University.  Over the next hundred years and more, Presidency College was Bengal’s pre-eminent centre of higher learning. Although a Constituent College of Calcutta University, it preserved a tradition of research matched by few universities in India. This gave a unique dimension to its undergraduate teaching.

Post : Junior Research Fellow (JRF)

Faculty Recruitment in Radha Govind University | 10 posts

The University is located in a rural area in co-existence with natural environment. It aims at empowering the youth of Jharkhand with vocational and skill development training, besides the teaching of traditional subjects, train them as a cultured citizen and prepare them for employment/selfemployment.  The University is also very much desirous to assist and encourage the poor and meritorious students in getting higher education in the campus. Our attempt will be to prepare the students for their holistic pe rsona lity deve lopment through inculcating leader's quality & responsibility.

Post : Faculty

PAREXEL looking for Senior Regulatory Affairs Associate | B.Pharm, M.Pharm

PAREXEL has supported the Bio-Tech and Pharmaceutical industries in helping the development of new drugs and treatments on a global basis. As a leading global biopharmaceutical service provider, they supply knowledge-based contract research, medical communications and consulting services across a broad range of therapeutic areas to the worldwide pharmaceutical, biotechnology and medical device industries.

Post : Senior Regulatory Affairs Associate

Require Territory Business Manager at Abbott India Limited | B.Pharm, B.Sc

Abbott India Limited is a subsidiary of Abbott Laboratories, USA, a global, iversified health care company devoted to the discovery, development, manufacture and marketing of pharmaceutical, diagnostic, nutritional and hospital products. The company now employs approximately 70,000 people and markets its products in 130 countries worldwide.

Post : Territory Business Manager

Over the last 20 years, three families have been unsuspectingly linked by an unknown illness. Researchers at the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, and other organizations have now identified the cause of the illness, a new disease called CRIA syndrome. The results were published in the journal Nature.

The U.S. Food and Drug Administration approved Ubrelvy (ubrogepant) tablets for the acute (immediate) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults. Ubrelvy is not indicated for the preventive treatment of migraine. It is the first drug in the class of oral calcitonin gene-related peptide receptor antagonists approved for the acute treatment of migraine.

The U.S. Food and Drug Administration has approved two applications for the first generics of Eliquis (apixaban) tablets to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. Apixaban is also indicated for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery. Additionally, apixaban is indicated for the treatment of DVT and PE and for the reduction in the risk of recurrent DVT and PE following initial therapy.